Whitnell & Co’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$156K Hold
2,400
0.05% 161
2019
Q3
$152K Hold
2,400
0.05% 158
2019
Q2
$162K Hold
2,400
0.06% 150
2019
Q1
$156K Hold
2,400
0.06% 152
2018
Q4
$150K Hold
2,400
0.07% 149
2018
Q3
$185K Hold
2,400
0.07% 131
2018
Q2
$170K Hold
2,400
0.07% 134
2018
Q1
$181K Hold
2,400
0.08% 130
2017
Q4
$172K Hold
2,400
0.07% 130
2017
Q3
$194K Hold
2,400
0.08% 124
2017
Q2
$170K Sell
2,400
-85
-3% -$5.66K 0.08% 129
2017
Q1
$169K Sell
2,485
-504
-17% -$35.4K 0.08% 129
2016
Q4
$214K Buy
2,989
+104
+4% +$7.73K 0.1% 120
2016
Q3
$228K Buy
2,885
+225
+8% +$18.3K 0.08% 130
2016
Q2
$222K Buy
2,660
+400
+18% +$35.5K 0.07% 131
2016
Q1
$208K Buy
2,260
+165
+8% +$14.9K 0.08% 138
2015
Q4
$212K Buy
2,095
+295
+16% +$30.7K 0.08% 136
2015
Q3
$177K Hold
1,800
0.07% 137
2015
Q2
$211K Sell
1,800
-200
-10% -$21.9K 0.08% 133
2015
Q1
$196K Hold
2,000
0.07% 132
2014
Q4
$189K Hold
2,000
0.07% 131
2014
Q3
$213K Hold
2,000
0.09% 131
2014
Q2
$166K Hold
2,000
0.08% 139
2014
Q1
$142K Hold
2,000
0.07% 145
2013
Q4
$150K Hold
2,000
0.07% 143
2013
Q3
$126K Hold
2,000
0.06% 147
2013
Q2
$103K Buy
+2,000
New +$104K 0.05% 151

Other funds holding GILD

Whitnell & Co's GILD Position: Q4 2019 in Review

Whitnell & Co held its Gilead Sciences (GILD) position steady in Q4 2019 at 2,400 shares worth $156K. The position accounts for 0.05% of the portfolio, ranked #161.

Whitnell & Co first reported a position in GILD in Q2 2013 and has held it in 27 quarters since. The position peaked at $228K in Q3 2016. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

  • Whitnell & Co held 2,400 shares of Gilead Sciences worth $156K as of Q4 2019.
  • Whitnell & Co left its Gilead Sciences share count unchanged in Q4 2019.
  • Gilead Sciences made up 0.05% of Whitnell & Co's portfolio in Q4 2019, its #161 holding.
  • Whitnell & Co first reported a position in Gilead Sciences in Q2 2013 and has held it in 27 quarters since.
  • Whitnell & Co's Gilead Sciences position peaked at $228K in Q3 2016.
  • 1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Whitnell & Co's 13F filing for Q4 2019, filed 11 Feb 2020.